Relationship between myocardial modelling and diastolic function in patients with essential hypertension;Relación entre modelado miocárdico y función diastólica en pacientes con hipertensión esencial

Medicina Clinica

Volumn 139, Issue 8, 2012, Pages 325-330

  Cortés, Raquel ^a   Roselló Lletí, Esther ^a   Portolés, Manuel ^a   Almenar, Luis ^a   Martínez Dolz, Luis ^a   Grigorian, Lilian ^b   García De Burgos, Fernando ^c   Carpena, Nuria ^a   Salvador, Antonio ^a   Bertomeu, Vicente ^d   Rivera, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL DO MEIXOEIRO   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Collagen; Cytokines; Diastolic function; Essential hypertension

Indexed keywords

FAS LIGAND; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; DIASTOLE; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

AGED; ANTIGENS, CD95; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RADIOIMMUNOASSAY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84866023625     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.08.008     Document Type: Article

References (35)

1. H.N. Sabbah Apoptotic cell death in heart failure Cardiovasc Res 45 2000 704 712
2. J.M. Capasso, T. Palackal, G. Olivetti, and P. Anversa Left ventricular failure induced by long-term hypertension in rats Circ Res 66 1990 1400 1412
3. E. Teiger, V.D. Than, L. Richard, C. Wisnewsky, B.S. Tea, and L. Gaboury Apoptosis in pressure overload-induced heart hypertrophy in the rat J Clin Invest 97 1996 2891 2897
4. M.A. Fortuño, S. Ravassa, A. Fortuño, G. Zalba, and J. Díez Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management Hypertension 38 2001 1406 1412
5. J. Díez Mechanisms of cardiac fibrosis in hypertension J Clin Hypertens (Greenwich) 9 2007 546 550
6. V.P. Van Empel, A.T. Bertrand, L. Hofstra, H.J. Crijns, P.A. Doevendans, and L.J. De Windt Myocyte apoptosis in heart failure Cardiovasc Res 67 2005 21 29
7. Y. Li, G. Takemura, K. Kosai, T. Takahashi, H. Okada, and S. Miyata Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodelling and heart failure Circ Res 95 2004 627 636
8. T. Okura, S. Watanabe, Y. Jiang, M. Nakamura, Y. Takata, and Z.H. Yang Soluble Fas ligand and atherosclerosis in hypertensive patients J Hypertens 20 2002 895 898
9. K. Nishigaki, S. Minatoguchi, M. Seishima, K. Asano, T. Noda, and N. Yasuda Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure J Am Coll Cardiol 29 1997 1214 1220
10. M. Valgimigli, C. Ceconi, P. Malagutti, E. Merli, O. Soukhomovskaia, and G. Francolini Tumour necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study Circulation 111 2005 863 870
11. E. Roselló-Lletí, M. Rivera, L. Martínez-Dolz, J.R. González Juanatey, R. Cortés, and A. Jordán Inflammatory Activation and left ventricular mass in essential hypertension Am J Hypertens 22 2009 444 450
12. R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, N.F. Murphy, and C. Conlon Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover Eur J Heart Fail 11 2009 191 197
13. J.I. Pérez-Calvo, J.L. Morales Rull, and F.J. Ruiz Ruiz La cistatina C: una proteína para la insuficiencia cardiaca Med Clin (Barc) 136 2011 158 162
14. J. Díez, C. Laviades, G. Mayor, M.J. Gil, and I. Monreal Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations Circulation 91 1995 1450 1456
15. M. Cicoira, A. Rossi, S. Bonapace, L. Zanolla, G. Golia, and L. Franceschini Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure J Card Fail 10 2004 403 411
16. M. Rivera, R. Taléns-Visconti, A. Jordán, R. Sirera, B. Sevilla, and V. Climent Myocardial remodelling and immunological activation in patients with heart failure Rev Esp Cardiol 59 2006 911 918
17. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
18. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, and I. Sachs Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
19. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines, Standards Committee, European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
20. M.J. Garcia, J.D. Thomas, and A.L. Klein New Doppler echocardiographic applications for the study of diastolic function J Am Coll Cardiol 32 1998 865 875
21. R. Taléns-Visconti, M. Rivera, V. Climent, R. Valero, L. Martínez-Dolz, and M.J. Sancho-Tello Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure Echocardiography 23 2006 295 302
22. A. González, M.A. Fortuño, R. Querejeta, S. Ravassa, B. López, and N. López Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res 59 2003 549 562
23. R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, C. Conlon, and A. Patle Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction Circulation 115 2007 888 895
24. J.E. Bishop, and G.J. Laurent Collagen turnover and its regulation in the normal and hypertrophying heart Eur Heart J 16 Suppl C 1995 38 44
25. F. Zannad, B. Dousset, and F. Alla Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship Hypertension 38 2001 1227 1232
26. K. Miwa, M. Asano, R. Horai, Y. Iwakura, S. Nagata, and T. Suda Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand Nat Med 4 1998 1287 1292
27. K. Yamamoto, T. Masuyama, Y. Sakata, N. Nishikawa, T. Mano, and J. Yoshida Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart Cardiovasc Res 55 2002 76 82
28. N. Moorjani, S. Westaby, J. Narula, P.A. Catarino, R. Brittin, and T.J. Kemp Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure Am J Cardiol 103 2009 1261 1268
29. S. Miyata, G. Takemura, K. Kosal, T. Takashashi, M. Esaki, and L. Li Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis Am J Pathol 176 2010 87 98
30. C. Badorff, H. Ruetten, S. Mueller, M. Stahmer, D. Gehring, and F. Jung Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload J Clin Invest 109 2002 373 381
31. H. Tashiro, T. Aoki, K. Sadamatsu, K. Ooe, T. Yamawaki, and S. Sagara Evaluation of the left ventricular diastolic function using three-dimensional echocardiography Echocardiography 25 2008 968 973
32. Y.P. Hou, J.L. Wu, Q. Fan, M.B. Liu, B.L. Yin, and L. Zhang Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment Clin Sci (Lond) 112 2007 299 304
33. R. Müller-Brunotte, T. Kahan, B. López, M. Edner, A. González, and J. Díez Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) J Hypertens 25 2007 1958 1966
34. M. Anguita, F. Toledano, C. León, and J.C. Castillo Hipertensión arterial, cardiopatía hipertensiva e insuficiencia cardiaca. Papel de los diuréticos de asa Med Clin (Barc) 131 2008 660 664
35. F. Alla, A. Kearney-Schwartz, A. Radauceanu, S. Das Dores, B. Dousset, and F. Zannad Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type ii diabetes Eur J Heart Fail 8 2006 147 153